Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure.
Koenig AL, Shchukina I, Amrute J, Andhey PS, Zaitsev K, Lai L, Bajpai G, Bredemeyer A, Smith G, Jones C, Terrebonne E, Rentschler SL, Artyomov MN, Lavine KJ. · 2022
Read Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. by Koenig AL, Shchukina I, Amrute J, Andhey PS, Zaitsev K, Lai L, Bajpai G, Bredemeyer A, Smith G, Jones C, Terrebonne E, Rentschler SL, Artyomov MN, Lavine KJ. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9364913.txt.
Introduction
Koenig and co-authors use single-cell methods to map how the human heart changes in failure. They merged cell and nucleus RNA data from 27 healthy donors and 18 people with dilated cardiomyopathy. Fifteen major heart cell types were defined. Age and disease signatures were read cell by cell.
Heart muscle cells converged toward shared disease states. Fibroblasts and immune myeloid cells, by contrast, split into many new states. Vessel lining cells and pericytes shifted their programs without gaining complexity. Heart failure carries lifetime risk of 20 to 45% and five-year death rates near 50%. The map names cell-specific programs that new drugs might target. It is offered as a public resource for heart failure research. Earlier human data sets were too small for this view.
Catalog record
| CREATOR | Koenig AL, Shchukina I, Amrute J, Andhey PS, Zaitsev K, Lai L, Bajpai G, Bredemeyer A, Smith G, Jones C, Terrebonne E, Rentschler SL, Artyomov MN, Lavine KJ. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure By Andrew L. Koenig, Irina Shchukina, Junedh Amrute, Prabhakar S. Andhey, Konstantin Zaitsev, Lulu Lai, Geetika Bajpai, Andrea Bredemeyer, Gabriella Smith, Cameran Jones, Emily Terrebonne, Stacey L. Rentschler Published in: Nature cardiovascular research DOI: 10.1038/s44161-022-00028-6 ABSTRACT Heart failure represents a major cause of morbidity and mortality worldwide. Single-cell transcriptomics have revolutionized our understanding of cell composition and associated gene expression. Through integrated analysis of single-cell and single-nucleus RNA-sequencing data generated from 27 healthy donors and 18 individuals with dilated cardiomyopathy, here we define the cell composition of the healthy and failing human heart. We identify cell-specific transcriptional signatures associated with age and heart failure and reveal the emergence of disease-associated cell states. Notably, cardiomyocytes converge toward common disease-associated cell states, whereas fibroblasts and myeloid cells undergo dramatic diversification. Endothelial cells and pericytes display global transcriptional shifts without changes in cell complexity. Collectively, our findings provide a comprehensive analysis of the cellular and transcriptomic landscape of human heart failure, identify cell type-specific transcriptional programs and disease-associated cell states and establish a valuable resource for the investigation of human heart failure. Single-cell and single-nucleus RNA sequencing (scRNA-seq and snRNA-seq, respectively) represent powerful new tools to identify cell types and their respective transcriptional signatures that reside within healthy and diseased tissues. Before the development of these technologies, our understanding of the cells that comprise human tissues and organs was restricted to routine histology and immunostaining analyses performed many decades ago. The rapid deployment of single-cell sequencing has revolutionized the field and resulted in the identification of previously unrecognized cell populations, including disease-specific cell states across a wide range of structures, including the brain, lung, liver, kidney and various malignancies1-5. Heart failure represents a major cause of morbidity and mortality worldwide and imparts large costs on healthcare systems ($30–50 billion year−1 in the United States)6,7. Despite advancements in patient care, heart failure remains prevalent (lifetime risk of 20–45%) and portends 5-year morality rates approaching 50%, highlighting the clinical need to develop new therapies8. While bulk RNA-seq has yielded important insights into disease mechanisms that contribute to heart failure pathogenesis9, cell-specific information is lost and much remains to be learned regarding the roles of individual cell types. Identification of cell-specific disease-associated programs may provide the insights and opportunities necessary to develop new approaches for heart failure. Recently, scRNA-seq and snRNA-seq was performed on healthy human heart tissue10,11. These studies yielded new information pertaining to common and rare cell populations within the healthy heart. Cardiomyocytes, fibroblasts, endothelial cells, pericytes, smooth muscles cells, myeloid cells, lymphoid cells, adipocytes and neural cells were readily identified and analyzed across anatomical sites. Distinct transcriptional states of atrial and ventricular cardiomyocytes were identified and validated using RNA in situ hybridization. Notable diversity was also observed among perivascular and immune cell types, including transcriptional signatures specific to different regions of heart. At present, little is understood regarding the functional relevance of cell diversity within major human cardiac cell populations. Furthermore, the impact of human cardiac disease on cell composition remains to be rigorously investigated. While extensive work has been carried out in mouse models of heart failure, current scRNA-seq datasets exploring human heart failure are small and lack the sample size necessary to elucidate the impact of disease on common and rare cardiac cell types12-21. Herein, we performed snRNA-seq and scRNA-seq on a large cohort of heart specimens obtained from healthy individuals and patients with chronic heart failure. We identified 15 major cardiac cell types from 45 individuals and explored the extent of cell diversity within each of these populations. Unsupervised clustering, differential gene expression and trajectory analyses revealed cell type-specific transcriptional programs and emergence of disease-associated cell states in the context of heart failure. We uncovered cell-specific influences of age on gene expression that differed based on disease state. Our data provide a comprehensive analysis of the cellular and transcriptomic landscape of the healthy and failing human heart and will serve as a valuable resource to the scientific community. RESULTS snRNA-seq and scRNA-seq reveal the cellular landscape of the human heart. To define the cellular and transcriptional landscape of the healthy and failing human heart, we obtained left ventricular (LV) cardiac tissue specimens from 28 non-diseased donors (donation after brain death) and 17 individuals with dilated (non-ischemic) cardiomyopathy (DCM). Non-diseased tissues were acquired from prospective donor hearts with normal LV function that were not used for transplantation due to the lack of a suitable recipient. DCM tissue was obtained from individuals undergoing implantation of an LV assist device or explanted hearts collected at the time of transplantation. Transmural myocardial samples from the apical and anterior segments of the LV were processed for either snRNA-seq (n = 38) or scRNA-seq (n = 7) using the 10X Genomics 5′ Single Cell platform (Fig. 1a, Extended Data Fig. 1 and Supplementary Table 1). Single-nucleus and single-cell libraries were sequenced, aligned to the human reference genome, filtered for quality control (QC). Unsupervised clustering, integration and differential expression analysis performed using Harmony and Seurat (Fig. 1b, Extended Data Fig. 1 and Supplementary Tables 2 and 3). Following QC, nuclei samples had average gene and feature counts per cell of 2,849 and 1,496, respectively, whereas those counts for cells were 4,893 and 1,966, respectively. The final integrated dataset consisted of 220,752 nuclei and 49,723 cells representative of 15 major cell types (Fig. 1c). Cell identities were validated by expression of cell-specific marker genes (Fig. 1d) and transcriptional signatures (Extended Data Figs. 2 and 3). Cell types identified in both snRNA-seq and scRNA-seq datasets included fibroblasts, endothelial cells, myeloid cells, pericytes, smooth muscle cells, T cells and natural killer (NK) cells, neurons/glia and B cells. A notable benefit of snRNA-seq is the ability to obtain reads from additional cell types that are not efficiently recovered from enzymatically digested tissue including cardiomyocytes, adipocytes, endocardial cells, lymphatics, epicardial cells and mast cells (Fig. 1e and Extended Data Figs. 2 and 3). The analyzed dataset was powered to investigate the influence of age, sex and disease state and severity on gene expression. Differential expression analysis using pseudobulk and single-cell approaches demonstrated substantial overlap (Supplementary Tables 4 and 5). Disease state had the most powerful influence on differential gene expression across cell types (Fig. 2a and Supplementary Table 21). Heart failure severity, as assessed by INTERMACS profile/score (predictor of outcomes in the advanced heart failure population) revealed evidence of differential expression in cardiomyocytes, endothelial, endocardial, fibroblast and myeloid cells (Fig. 2b and Supplementary Table 22)22,23. We also observed changes in cardiac cell composition as a function of disease state. Individuals with DCM had decreased numbers of cardiomyocytes, pericytes and mast cells; and increased numbers of fibroblasts, myeloid cells, T/NK cells and lymphatics (Supplementary Table 6). Many of these changes were observed in both men and women (Supplementary Tables 7 and 8). Heart failure severity was not associated with changes in cell composition (Supplementary Table 9). Substantially fewer differentially expressed genes (DEGs) were detected comparing sex in either non-diseased donors or individuals with DCM. The majority of differentially expressed transcripts were located on the X and Y chromosomes including XIST, TSIX and TTTY genes (Fig. 2c and Extended Data Fig. 4). We did not